AGIOS PHARMACEUTICALS, INC. AGIO
- PYRUKYND — Pyruvate Kinase Deficiency Approved
- AQVESME — Alpha-Thalassemia Approved
- AQVESME — Beta-Thalassemia Approved
- PYRUKYND — Sickle Cell Disease NDA Submitted
Home › Targets › pyruvate kinase R
pyruvate kinase R (1 companies · 4 programs)
Companies with an active program directed at pyruvate kinase R.